AU2001246916A1 - Oxadiazole derivatives having anticancer effects - Google Patents

Oxadiazole derivatives having anticancer effects

Info

Publication number
AU2001246916A1
AU2001246916A1 AU2001246916A AU2001246916A AU2001246916A1 AU 2001246916 A1 AU2001246916 A1 AU 2001246916A1 AU 2001246916 A AU2001246916 A AU 2001246916A AU 2001246916 A AU2001246916 A AU 2001246916A AU 2001246916 A1 AU2001246916 A1 AU 2001246916A1
Authority
AU
Australia
Prior art keywords
oxadiazole derivatives
anticancer effects
anticancer
effects
oxadiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001246916A
Other versions
AU2001246916B2 (en
Inventor
Ryuji Maekawa
Fumihiko Watanabe
Takayuki Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority claimed from PCT/JP2001/003214 external-priority patent/WO2001083463A1/en
Publication of AU2001246916A1 publication Critical patent/AU2001246916A1/en
Application granted granted Critical
Publication of AU2001246916B2 publication Critical patent/AU2001246916B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001246916A 2000-04-21 2001-04-16 Oxadiazole derivatives having anticancer effects Ceased AU2001246916B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-120234 2000-04-21
JP2000120234 2000-04-21
PCT/JP2001/003214 WO2001083463A1 (en) 2000-04-21 2001-04-16 Oxadiazole derivatives having anticancer effects

Publications (2)

Publication Number Publication Date
AU2001246916A1 true AU2001246916A1 (en) 2002-01-31
AU2001246916B2 AU2001246916B2 (en) 2004-10-07

Family

ID=18631080

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4691601A Pending AU4691601A (en) 2000-04-21 2001-04-16 Oxadiazole derivatives having anticancer effects
AU2001246916A Ceased AU2001246916B2 (en) 2000-04-21 2001-04-16 Oxadiazole derivatives having anticancer effects

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU4691601A Pending AU4691601A (en) 2000-04-21 2001-04-16 Oxadiazole derivatives having anticancer effects

Country Status (16)

Country Link
US (2) US6720343B2 (en)
EP (1) EP1277744A4 (en)
JP (1) JP3974781B2 (en)
KR (1) KR100542780B1 (en)
CN (1) CN1199956C (en)
AU (2) AU4691601A (en)
BR (1) BR0110211A (en)
CA (1) CA2406685C (en)
HU (1) HUP0300619A3 (en)
MX (1) MXPA02010325A (en)
NO (1) NO324868B1 (en)
PL (1) PL203161B1 (en)
RU (1) RU2275371C2 (en)
TW (1) TWI294877B (en)
WO (1) WO2001083463A1 (en)
ZA (1) ZA200208307B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2005012268A1 (en) 2003-07-30 2005-02-10 Shionogi & Co., Ltd. Sulfonamide derivative having isoxazole ring
WO2006047195A2 (en) * 2004-10-22 2006-05-04 Merck & Co., Inc. 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
GB0601744D0 (en) 2006-01-27 2006-03-08 Novartis Ag Organic compounds
UA91129C2 (en) * 2006-05-09 2010-06-25 Пфайзер Продактс Инк. Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
KR100783585B1 (en) 2006-08-22 2007-12-07 한국생명공학연구원 Agent for prevention or treatment of cancer comprising oxadiazole urea compound obstructing activity of stat
AU2008293542B9 (en) 2007-08-27 2014-08-07 Dart Neuroscience (Cayman) Ltd. Therapeutic isoxazole compounds
AU2008334297A1 (en) * 2007-12-10 2009-06-18 Actelion Pharmaceuticals Ltd Thiophene derivatives as agonists of S1P1/EDG1
AR077969A1 (en) 2009-08-31 2011-10-05 Abbott Healthcare Products Bv DERIVATIVES OF (TIO) MORFOLINA COMOMODULADORES DE S1P
TWI522361B (en) 2010-07-09 2016-02-21 艾伯維公司 Fused heterocyclic derivatives as s1p modulators
TW201206893A (en) 2010-07-09 2012-02-16 Abbott Healthcare Products Bv Bisaryl (thio) morpholine derivatives as S1P modulators
TW201643169A (en) 2010-07-09 2016-12-16 艾伯維股份有限公司 Spiro-piperidine derivatives as S1P modulators
CN103450167A (en) * 2012-05-28 2013-12-18 南京大学 Acylhydrazone derivatives containing 1, 3, 4-oxadiazole and pyrazine ring and preparation method and uses thereof
US10710994B2 (en) * 2018-03-19 2020-07-14 Genentech, Inc. Oxadiazole transient receptor potential channel inhibitors
CA3159378A1 (en) 2019-10-31 2021-05-06 ESCAPE Bio, Inc. Solid forms of an s1p-receptor modulator
CN113264899B (en) * 2021-04-09 2022-06-14 台州学院 1,3,5-oxadiazine compound and preparation and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29293A (en) * 1997-07-22 1999-01-28 Shionogi & Co COMPOSITION FOR TREATMENT OR PREVENT GLOMERULOPATHY (Fraction from No. W20000054)
WO2000015213A1 (en) * 1998-09-11 2000-03-23 Shionogi & Co., Ltd. Remedal or preventive agent for congestive heart failure

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002215218A1 (en) Isoxazole derivatives
AU2001271027A1 (en) Ester derivatives
AU2001246835A1 (en) Ethylenediamine derivatives
AU2002230562A1 (en) Positive-return gambling
AU2882801A (en) Azepine derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2001246916A1 (en) Oxadiazole derivatives having anticancer effects
AU4691601A (en) Oxadiazole derivatives having anticancer effects
AU2000223275A1 (en) Novel triazole derivatives
AU2001278694A1 (en) Avermectin derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU5256301A (en) Froindazole derivative
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2002221099A1 (en) Combination drugs
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2002220578A1 (en) O-substituted 6-methyl-tramadol derivatives
AU4497500A (en) Igniter
AU2001284039A1 (en) Chromanone derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives